| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| OPNT | OPIANT PHARMACEUTICALS, INC. | Ellison Mark Jason Heath | Chief Development Officer | Mar 02, 2023 | Option Exercise | $20.00 | 20,751 | 415,020 | 11,736 | Mar 03, 2023, 09:16 AM | |
| OPNT | OPIANT PHARMACEUTICALS, INC. | Ellison Mark Jason Heath | Chief Development Officer | Mar 02, 2023 | Option Exercise | $20.00 | 9,680 | 193,600 | 0 | Mar 03, 2023, 09:16 AM | |
| OPNT | OPIANT PHARMACEUTICALS, INC. | Ellison Mark Jason Heath | Chief Development Officer | Jan 27, 2023 | Sale | $20.26 | 610 | 12,359 | 18,751 | Jan 31, 2023, 04:21 PM | |
| OPNT | OPIANT PHARMACEUTICALS, INC. | Ellison Mark Jason Heath | Chief Development Officer | Jan 09, 2023 | Sale | $20.20 | 469 | 9,474 | 19,361 | Jan 09, 2023, 05:13 PM | |
| OPNT | OPIANT PHARMACEUTICALS, INC. | Ellison Mark Jason Heath | Chief Development Officer | Jan 05, 2023 | Sale | $20.20 | 1,806 | 36,481 | 19,830 | Jan 05, 2023, 05:07 PM | |
| OPNT | OPIANT PHARMACEUTICALS, INC. | Ellison Mark Jason Heath | UK Managing Director | Jul 29, 2019 | Option Exercise | $11.02 | 54,470 | 600,002 | 30,000 | Jul 30, 2019, 04:04 PM |
Menu